Related Experiment Video
Updated: Feb 11, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
VV extracorporeal life support for the Third Millennium: will we need anticoagulation?
Danny Eytan1, Yuval Bitterman1, Gail M Annich2
1Department of Pediatric Critical Care, Rambam Medical Center, Haifa, Israel.
Abstract:
Since the late 1600's medicine and science have entertained the idea of extracorporeal circulation. With this technology to allow for cardiac and pulmonary support came the development of anticoagulation. Although this advanced the technology and capabilities of extracorporeal life support, it was not without complications and risks. The most common complications in extracorporeal life support (ECLS) present day are related to hemorrhage and thrombus due to the need for systemic anticoagulation and the challenges associated with it. This review focuses on present day techniques for anticoagulation for ECLS and what future surface modifications may do to obviate the use of systemic anticoagulation entirely.
More Related Videos
05:36Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Half-life of a Reaction
Characteristics of Life
The Angiosperm Life Cycle
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
The Tree of Life - Bacteria, Archaea, Eukaryotes